Indicate by check mark whether the registrant
(1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding
12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days.
Indicate by check mark whether the registrant
has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted
and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such
shorter period that the registrant was required to submit and post such files).
Indicate by check mark whether the registrant
is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth
company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting
company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act:
If an emerging growth company,
indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or
revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
☐
Indicate by check mark whether the registrant
is a shell company (as defined in Section 12b-2 of the exchange Act)
Number of shares outstanding of the issuer’s Common Stock
as of May 15, 2019: 5,761,980.
PART I–FINANCIAL INFORMATION
Item 1. Financial Statements.
iSign Solutions
Inc.
Condensed Consolidated
Balance Sheets
(In thousands)
|
|
March 31,
|
|
|
December 31,
|
|
|
|
2019
|
|
|
2018
|
|
|
|
Unaudited
|
|
|
|
|
Assets
|
|
|
|
|
|
|
Current assets:
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
280
|
|
|
$
|
335
|
|
Accounts receivable, net of allowance of $1 at March 31, 2019 and $1 at December
31, 2018, respectively
|
|
|
43
|
|
|
|
84
|
|
Prepaid expenses and other current assets
|
|
|
59
|
|
|
|
46
|
|
Total current assets
|
|
|
382
|
|
|
|
465
|
|
Property and equipment, net
|
|
|
3
|
|
|
|
2
|
|
Other assets
|
|
|
5
|
|
|
|
5
|
|
Total assets
|
|
$
|
390
|
|
|
$
|
472
|
|
|
|
|
|
|
|
|
|
|
Liabilities and Stockholders’ Deficit
|
|
|
|
|
|
|
|
|
Current liabilities:
|
|
|
|
|
|
|
|
|
Accounts payable
|
|
$
|
1,266
|
|
|
$
|
1,280
|
|
Short-term debt, net
|
|
|
2,220
|
|
|
|
2,210
|
|
Accrued compensation
|
|
|
78
|
|
|
|
81
|
|
Other accrued liabilities
|
|
|
598
|
|
|
|
524
|
|
Deferred revenue
|
|
|
362
|
|
|
|
281
|
|
Total current liabilities
|
|
|
4,524
|
|
|
|
4,376
|
|
Deferred revenue long-term
|
|
|
–
|
|
|
|
36
|
|
Other long-term liabilities
|
|
|
703
|
|
|
|
665
|
|
Total liabilities
|
|
|
5,227
|
|
|
|
5,077
|
|
Commitments and contingencies
|
|
|
|
|
|
|
|
|
Stockholders’ equity (deficit):
|
|
|
|
|
|
|
|
|
Common stock, $0.01 par value; 2,000,000 shares authorized;
5,760 shares issued and outstanding at March 31, 2019 and December 31, 2018, respectively
|
|
|
58
|
|
|
|
58
|
|
Treasury shares, 5 at March 31, 2019 and December 31, 2018, respectively
|
|
|
(325
|
)
|
|
|
(325
|
)
|
Additional paid in capital
|
|
|
129,310
|
|
|
|
129,251
|
|
Accumulated deficit
|
|
|
(133,880
|
)
|
|
|
(133,589
|
)
|
Total stockholders’ deficit
|
|
|
(4,837
|
)
|
|
|
(4,605
|
)
|
Total liabilities and stockholders’ deficit
|
|
$
|
390
|
|
|
$
|
472
|
|
See accompanying notes to these Condensed
Consolidated Financial Statements
iSign Solutions
Inc.
Condensed Consolidated
Statements of Operations
Unaudited
(In thousands, except
per share amounts)
|
|
Three Months Ended
|
|
|
|
March 31,
|
|
|
|
2019
|
|
|
2018
|
|
|
|
|
|
|
|
|
Revenue:
|
|
|
|
|
|
|
Product
|
|
$
|
41
|
|
|
$
|
40
|
|
Maintenance
|
|
|
158
|
|
|
|
174
|
|
Total revenue
|
|
|
199
|
|
|
|
214
|
|
|
|
|
|
|
|
|
|
|
Operating costs and expenses:
|
|
|
|
|
|
|
|
|
Cost of sales:
|
|
|
|
|
|
|
|
|
Product
|
|
|
2
|
|
|
|
3
|
|
Maintenance
|
|
|
16
|
|
|
|
7
|
|
Research and development
|
|
|
171
|
|
|
|
229
|
|
Sales and marketing
|
|
|
26
|
|
|
|
19
|
|
General and administrative
|
|
|
204
|
|
|
|
176
|
|
Total operating costs and expenses
|
|
|
419
|
|
|
|
434
|
|
|
|
|
|
|
|
|
|
|
Loss from operations
|
|
|
(220
|
)
|
|
|
(220
|
)
|
|
|
|
|
|
|
|
|
|
Interest expense:
|
|
|
|
|
|
|
|
|
Related party
|
|
|
(14
|
)
|
|
|
(8
|
)
|
Other
|
|
|
(47
|
)
|
|
|
(30
|
)
|
Amortization of debt discount:
|
|
|
|
|
|
|
|
|
Related party
|
|
|
(3
|
)
|
|
|
(7
|
)
|
Other
|
|
|
(7
|
)
|
|
|
(17
|
)
|
Loss before income tax expense
|
|
|
(291
|
)
|
|
|
(282
|
)
|
|
|
|
|
|
|
|
|
|
Income tax expense
|
|
|
─
|
|
|
|
(2
|
)
|
Net loss
|
|
$
|
(291
|
)
|
|
$
|
(284
|
)
|
Basic and diluted net loss per common share
|
|
$
|
(0.05
|
)
|
|
$
|
(0.05
|
)
|
Weighted average common shares outstanding, basic and diluted
|
|
|
5,762
|
|
|
|
5,762
|
|
See accompanying notes to these Condensed
Consolidated Financial Statements
iSign Solutions
Inc.
Condensed Consolidated
Statements of Stockholders’ Equity
Unaudited
(In thousands)
|
|
Common Stock
|
|
|
Treasury Stock
|
|
|
Additional
Paid-in
|
|
|
Accumulated
|
|
|
Total
Stockholders’
|
|
|
|
Shares
|
|
|
Amount
|
|
|
Shares
|
|
|
Amount
|
|
|
Capital
|
|
|
Deficit
|
|
|
Equity
|
|
Balance January 1, 2019
|
|
|
5,760
|
|
|
$
|
58
|
|
|
|
5
|
|
|
$
|
(325
|
)
|
|
$
|
129,251
|
|
|
$
|
(133,589
|
)
|
|
$
|
(4,605
|
)
|
Stock-based compensation
|
|
|
─
|
|
|
|
─
|
|
|
|
─
|
|
|
|
─
|
|
|
$
|
59
|
|
|
|
─
|
|
|
|
59
|
|
Net loss
|
|
|
─
|
|
|
|
─
|
|
|
|
─
|
|
|
|
─
|
|
|
|
─
|
|
|
|
(291
|
)
|
|
|
(291
|
)
|
Balance, March 31, 2019
|
|
|
5,760
|
|
|
$
|
58
|
|
|
|
5
|
|
|
$
|
(325
|
)
|
|
$
|
129,310
|
|
|
$
|
(133,880
|
)
|
|
$
|
(4,837
|
)
|
|
|
Common Stock
|
|
|
Treasury Stock
|
|
|
Additional
Paid-in
|
|
|
Accumulated
|
|
|
Total
Stockholders’
|
|
|
|
Shares
|
|
|
Amount
|
|
|
Shares
|
|
|
Amount
|
|
|
Capital
|
|
|
Deficit
|
|
|
equity
|
|
Balance January 1, 2018
|
|
|
5,760
|
|
|
$
|
58
|
|
|
|
5
|
|
|
$
|
(325
|
)
|
|
$
|
129,027
|
|
|
$
|
(132,562
|
)
|
|
$
|
(3,802
|
)
|
Stock-based compensation
|
|
|
─
|
|
|
|
─
|
|
|
|
─
|
|
|
|
─
|
|
|
|
48
|
|
|
|
─
|
|
|
|
48
|
|
Net loss
|
|
|
─
|
|
|
|
─
|
|
|
|
─
|
|
|
|
─
|
|
|
|
─
|
|
|
|
(284
|
)
|
|
|
(284
|
)
|
Balance, March 31, 2018
|
|
|
5,760
|
|
|
$
|
58
|
|
|
|
5
|
|
|
$
|
(325
|
)
|
|
$
|
129,075
|
|
|
$
|
(132,846
|
)
|
|
$
|
(4,038
|
)
|
See accompanying notes to these Condensed
Consolidated Financial Statements
iSign Solutions
Inc.
Condensed Consolidated
Statements of Cash Flows
Unaudited
(In thousands)
|
|
Three Months Ended
March 31,
|
|
|
|
2019
|
|
|
2018
|
|
Cash flows from operating activities:
|
|
|
|
|
|
|
|
|
Net loss
|
|
$
|
(291
|
)
|
|
$
|
(284
|
)
|
Adjustments to reconcile net loss to net cash used
in operating activities:
|
|
|
|
|
|
|
|
|
Depreciation and amortization
|
|
|
1
|
|
|
|
2
|
|
Stock-based compensation
|
|
|
59
|
|
|
|
48
|
|
Amortization of debt discount
|
|
|
10
|
|
|
|
24
|
|
Changes in operating assets and liabilities:
|
|
|
|
|
|
|
|
|
Accounts receivable, net
|
|
|
41
|
|
|
|
14
|
|
Prepaid expenses and other assets
|
|
|
(13
|
)
|
|
|
6
|
|
Accounts payable
|
|
|
(14
|
)
|
|
|
(14
|
)
|
Accrued compensation
|
|
|
(3
|
)
|
|
|
(54
|
)
|
Other accrued and long-term liabilities
|
|
|
112
|
|
|
|
79
|
|
Deferred revenue
|
|
|
45
|
|
|
|
10
|
|
Net cash used in operating activities
|
|
|
(53
|
)
|
|
|
(169
|
)
|
|
|
|
|
|
|
|
|
|
Cash flows from investing activities:
|
|
|
|
|
|
|
|
|
Acquisition of property and equipment
|
|
|
(2
|
)
|
|
|
(─
|
)
|
Net cash used in investing activities
|
|
|
(2
|
)
|
|
|
(─
|
)
|
|
|
|
|
|
|
|
|
|
Net decrease in cash and cash equivalents
|
|
|
(55
|
)
|
|
|
(169
|
)
|
Cash and cash equivalents at beginning of period
|
|
|
335
|
|
|
|
285
|
|
Cash and cash equivalents at end of period
|
|
$
|
280
|
|
|
$
|
116
|
|
See accompanying
notes to these Condensed Consolidated Financial Statements
iSign Solutions
Inc.
Condensed Consolidated
Statements of Cash Flows (Continued)
Unaudited
(In thousands)
|
|
Three
Months Ended
March
31,
|
|
|
|
2019
|
|
|
2018
|
|
Supplementary disclosure of cash flow information
|
|
|
|
|
|
|
Interest paid
|
|
$
|
1
|
|
|
$
|
─
|
|
Income taxes paid
|
|
$
|
─
|
|
|
$
|
2
|
|
See accompanying notes to these Condensed
Consolidated Financial Statements
iSign Solutions Inc.
FORM 10-Q
(In thousands, except per share amounts)
|
1.
|
Nature of Business and Summary of
Significant Accounting Policies
|
Nature of Business
iSign Solutions Inc. and its
subsidiary is a leading supplier of digital transaction management (DTM) software enabling the paperless, secure and cost-effective
management and authentication of document-based transactions. iSign’s solutions encompass a wide array of functionality
and services, including electronic signatures, simple-to-complex workflow management and various options for biometric authentication.
These solutions are available across virtually all enterprise, desktop and mobile environments as a seamlessly integrated platform
for both ad-hoc and fully automated transactions. iSign’s platform can be deployed both on premise and as a cloud-based
(“SaaS”) service, with the ability to easily transition between deployment models. The Company is headquartered
in San Jose, California. The Company’s products include SignatureOne™ Ceremony™ Server, the iSign™ suite
of products and services, including iSign™ Enterprise and iSign™ Console™, and Sign-it™ programs.
Basis of Presentation
The financial information
contained herein should be read in conjunction with the Company’s consolidated audited financial statements and notes thereto
included in its Annual Report on Form 10-K for the year ended December 31, 2018.
The accompanying unaudited
condensed consolidated financial statements of the Company have been prepared pursuant to the rules and regulations of the Securities
and Exchange Commission. Accordingly, they do not include all of the information and footnotes required by accounting principles
generally accepted in the United States of America (“GAAP”) for complete consolidated financial statements. In the
opinion of management, the unaudited condensed consolidated financial statements included in this quarterly report reflect all
adjustments (consisting only of normal recurring adjustments) that the Company considers necessary for a fair presentation of
its financial position at the dates presented and the Company’s results of operations and cash flows for the periods presented.
The Company’s interim results are not necessarily indicative of the results to be expected for the entire year.
Going Concern
The accompanying unaudited
condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern. The
Company has incurred significant cumulative losses since its inception and, at March 31, 2019 the Company’s accumulated
deficit was $133,880. The Company has primarily met its working capital needs through the sale of debt and equity securities.
As of March 31, 2019, the Company’s cash balance was $280. These factors raise substantial doubt about the Company’s
ability to continue as a going concern.
There can be no assurance
that the Company will be successful in securing adequate capital resources to fund planned operations or that any additional funds
will be available to the Company when needed, or if available, will be available on favorable terms or in amounts required by
the Company. If the Company is unable to obtain adequate capital resources to fund operations, it may be required to delay, scale
back or eliminate some or all of its operations, which may have a material adverse effect on the Company’s business, results
of operations and ability to operate as a going concern. The unaudited condensed consolidated financial statements do not include
any adjustments that might result from the outcome of this uncertainty.
iSign Solutions Inc.
FORM 10-Q
(In thousands, except per share amounts)
|
1.
|
Nature of Business and Summary of
Significant Accounting Policies (continued)
|
Accounting Changes and
Recent Accounting Pronouncements
Accounting Standards Update
No. 2019-01, Leases (Topic 842), Codification Improvements. The amendments in this Update include the following items: (1) determining
the fair value of the underlying asset by lessors that are not manufacturers or dealers; (2) presentation on the statement of
cash flows—sales-type and direct financing leases; and (3) transition disclosures related to Topic 250, Accounting Changes
and Error Corrections. The amendments in ASU 2019-01 for Issue 1 affect all lessors that are not manufacturers or dealers (generally
financial institutions and captive finance companies); for Issue 2, all lessors that are depository and lending entities within
the scope of Topic 942; for Issue 3, all entities that are lessees or lessors. The effective date of the amendments in ASU 2019-01
are for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years.
The Company adopted ASU 2019-01
effective January 1, 2019. The adoption of ASU 2019-01 will have no impact on the Company’s financial statements.
The following table summarizes
accounts receivable and revenue concentrations:
|
|
Accounts Receivable
As of March 31,
|
|
|
Total Revenue
As of March 31,
|
|
|
|
2019
|
|
|
2018
|
|
|
2019
|
|
|
2018
|
|
Customer #1
|
|
|
–
|
|
|
|
–
|
|
|
|
12
|
%
|
|
|
14
|
%
|
Customer #2
|
|
|
83
|
%
|
|
|
76
|
%
|
|
|
17
|
%
|
|
|
11
|
%
|
Customer #3
|
|
|
–
|
|
|
|
–
|
|
|
|
18
|
%
|
|
|
16
|
%
|
Customer #4
|
|
|
–
|
|
|
|
–
|
|
|
|
20
|
%
|
|
|
20
|
%
|
Customer #5
|
|
|
–
|
|
|
|
16
|
%
|
|
|
–
|
|
|
|
–
|
|
Total concentration
|
|
|
83
|
%
|
|
|
92
|
%
|
|
|
67
|
%
|
|
|
61
|
%
|
The Company calculates basic
net loss per share based on the weighted average number of shares outstanding, and when applicable, diluted net income per share,
which is based on the weighted average number of shares and potential dilutive shares outstanding.
The following table lists shares
and warrants that were excluded from the calculation of diluted earnings per share as the inclusion of shares from the assumed
exercise of such options and warrants would be anti-dilutive:
|
|
For
the
Three Months Ended
|
|
|
|
March 31,
2019
|
|
|
March 31,
2018
|
|
|
|
|
|
|
|
|
Stock options
|
|
|
1,077
|
|
|
|
736
|
|
Warrants
|
|
|
2,813
|
|
|
|
1,839
|
|
iSign Solutions Inc.
FORM 10-Q
(In thousands, except per share amounts)
Advances:
In April, May, and June 2018,
the Company received, from investors, advances aggregating $115 in cash against certain accounts receivable of the Company. Upon
collection of an invoice, the Company would repay the advance to the lenders on a pro rata basis together with a 5% advance fee.
The receivables were collected and $40 of the advances were repaid in May 2018, along with $2 in advance fees per the agreement.
The advance fees were recorded as interest expense in the quarter ended June 30, 2018. The remaining $75 advances were converted
into secured convertible notes in August 2018.
Notes payable:
In August 2018, the Company issued
secured convertible promissory notes to investors and affiliates of the Company aggregating $341, of which $205 was paid in cash,
$75 was exchanged for the remaining advances described above and $61 was in the form of an Original Issue Discount (“OID”)
on these amounts. The secured notes are mandatorily convertible into Common Stock at a conversion rate of the lesser of $0.50
per share or the price per share of Common Stock upon closing a new financing of at least $1,000 in aggregate proceeds. The secured
notes bear interest at the rate of 10% per annum, are due December 31, 2019 and are secured by an interest in all the Company’s
rights, title and interest in, to and under its intellectual property. Should the secured notes remain outstanding following the
maturity date an additional 30% of the note’s principal amount shall become due and payable.
In December 2018, the Company
issued short-term unsecured convertible promissory notes to investors and affiliates of the Company aggregating $346 in cash.
The short-term notes are mandatorily convertible into Common Stock at a conversion rate of the lesser of $0.50 per share or the
price per share of Common Stock, upon closing a new debt and/or equity financing of at least $1,000 in aggregate proceeds. The
notes bear interest at the rate of 10% per annum and are due December 31, 2019.
The Company used the funds received
from the above financing for working capital and general corporate purposes.
During the three months ended
March 31, 2019, the Company accrued $61 of interest expense, $53 associated with the notes, of which $13 was to related parties
and $40 was to other investors. For the three months ended March 31, 2018, the Company accrued $38 of interest expense, $32 associated
with the notes, of which $8 was to related parties and $24 was to other investors.
The Company recorded $10 and
$24 in debt discount amortization for the three months ended March 31, 2019 and 2018, respectively.
|
5.
|
Stockholders’ Equity (Deficit)
|
Stock-based compensation expense
is based on the estimated grant date fair value of the portion of stock-based payment awards that are ultimately expected to vest
during the period. The grant date fair value of stock-based awards to employees and directors is calculated using the Black-Scholes-Merton
valuation model.
Forfeitures of stock-based payment
awards are estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those
estimates. The estimated average forfeiture rate for the three months ended March 31, 2019 and 2018 was approximately 0.11% and
5.95%, respectively, based on historical data.
iSign Solutions Inc.
FORM 10-Q
(In thousands, except per share amounts)
|
5.
|
Stockholders’ Equity (Deficit)
(continued)
|
Valuation and Expense Information:
The weighted-average fair value
of stock-based compensation is based on the Black-Scholes-Merton valuation model. Forfeitures are estimated and it is assumed
no dividends will be declared. The estimated fair value of stock-based compensation awards to employees is amortized over the
vesting period of the options.
The Company granted stock options
to purchase 40,000 shares of common stock during the three months ended March 31, 2019. No options were granted during the three
months ended March 31, 2018. There were no stock options exercised during the three months ended March 31, 2019 and 2018, respectively.
The fair value calculations for
the stock options granted are based on the following assumptions:
|
|
Three Months Ended
March 31,
2019
|
|
Risk free interest rate
|
|
|
2.30
|
%
|
Expected life (years)
|
|
|
6.1
|
|
Expected volatility
|
|
|
191.65
|
%
|
Expected dividend yield
|
|
|
None
|
|
The following table summarizes
the allocation of stock-based compensation expense for the three months ended March 31:
|
|
2019
|
|
|
2018
|
|
Research and development
|
|
$
|
10
|
|
|
$
|
31
|
|
Sales and marketing
|
|
|
–
|
|
|
|
–
|
|
General and administrative
|
|
|
40
|
|
|
|
13
|
|
Director
|
|
|
9
|
|
|
|
4
|
|
Total stock-based compensation
|
|
$
|
59
|
|
|
$
|
48
|
|
A summary of option activity
under the Company’s plans for the three months ended March 31, 2019 and 2018 is as follows:
|
|
2019
|
|
|
2018
|
|
Options
|
|
Shares
|
|
|
Weighted
Average Exercise Price per share
|
|
|
Weighted
Average Remaining Contractual Term (Years)
|
|
|
Aggregate
Intrinsic Value
|
|
|
Shares
|
|
|
Weighted
Average Exercise Price per share
|
|
|
Weighted
Average Remaining Contractual Term (Years)
|
|
|
Aggregate
Intrinsic Value
|
|
Outstanding at January 1
|
|
|
1,037
|
|
|
$
|
1.65
|
|
|
|
–
|
|
|
$
|
–
|
|
|
|
736
|
|
|
$
|
3.65
|
|
|
|
–
|
|
|
|
–
|
|
Granted
|
|
|
40
|
|
|
$
|
0.50
|
|
|
|
–
|
|
|
|
–
|
|
|
|
–
|
|
|
$
|
–
|
|
|
|
–
|
|
|
|
–
|
|
Outstanding at March 31
|
|
|
1,077
|
|
|
$
|
1.61
|
|
|
|
5.72
|
|
|
$
|
–
|
|
|
|
736
|
|
|
$
|
3.65
|
|
|
|
6.11
|
|
|
|
–
|
|
Vested and expected to vest at
March 31
|
|
|
1,077
|
|
|
$
|
1.61
|
|
|
|
5.72
|
|
|
$
|
–
|
|
|
|
702
|
|
|
$
|
3.86
|
|
|
|
6.09
|
|
|
$
|
–
|
|
Exercisable at March 31
|
|
|
402
|
|
|
$
|
3.24
|
|
|
|
5.28
|
|
|
$
|
–
|
|
|
|
153
|
|
|
$
|
15.67
|
|
|
|
4.82
|
|
|
$
|
–
|
|
iSign Solutions Inc.
FORM 10-Q
(In thousands, except per share amounts)
|
5.
|
Stockholders’ Equity (Deficit)
(continued)
|
The following table summarizes
significant ranges of outstanding and exercisable options as of March 31, 2019:
|
|
Options Outstanding
|
|
|
Options Exercisable
|
|
Range of Exercise Prices
|
|
Number Outstanding
|
|
|
Weighted Average Remaining Contractual Term (in
years)
|
|
|
Weighted Average Exercise Price
|
|
|
Number Outstanding
|
|
|
Weighted Average Exercise Price
|
|
$0.01 - $0.50
|
|
|
655
|
|
|
|
5.49
|
|
|
$
|
0.50
|
|
|
|
307
|
|
|
$
|
0.50
|
|
$0.51 - $1.00
|
|
|
393
|
|
|
|
6.36
|
|
|
|
0.78
|
|
|
|
66
|
|
|
|
0.78
|
|
$1.01 - $25.00
|
|
|
2
|
|
|
|
3.33
|
|
|
|
15.94
|
|
|
|
2
|
|
|
|
15.94
|
|
$25.00 - $625.00
|
|
|
27
|
|
|
|
2.00
|
|
|
|
38.81
|
|
|
|
27
|
|
|
|
38.81
|
|
Total
|
|
|
1,077
|
|
|
|
5.72
|
|
|
|
1.61
|
|
|
|
402
|
|
|
|
3.24
|
|
A summary of the status of the
Company’s non-vested shares as of March 31, 2019 is as follows:
Non-vested Shares
|
|
Shares
|
|
|
Weighted Average Grant-Date Fair Value
|
|
|
|
|
|
|
|
|
Non-vested at January 1, 2019
|
|
|
718
|
|
|
$
|
0.54
|
|
Granted
|
|
|
40
|
|
|
$
|
0.50
|
|
Vested
|
|
|
(83
|
)
|
|
$
|
0.65
|
|
Non-vested at March 31, 2019
|
|
|
675
|
|
|
$
|
0.52
|
|
As of March 31, 2019, there was $127 of total unrecognized
compensation expense related to non-vested stock-based compensation arrangements granted under the plans. The unrecognized compensation
expense is expected to be realized over a weighted average period of 2.60 years.
Warrants
On February 6, 2019, the Company
issued warrants to purchase 985,000 shares of common stock to 4 consultants and an employee in connection with the accrued compensation
owed by the Company to the employee and consultants. The warrants are exercisable for three years with an exercise price of $0.50
per share. The warrants may not be exercised for cash or on a cashless basis, and may solely be exercised using the holder’s
outstanding accrued compensation on the date of exercise.
A summary of the warrant activity to purchase shares
of Common Stock for the three months ended March 31 is as follows:
|
|
2019
|
|
|
2018
|
|
|
|
Shares
|
|
|
Weighted Average Exercise Price
|
|
|
Shares
|
|
|
Weighted Average Exercise Price
|
|
Outstanding at beginning of period
|
|
|
1,828
|
|
|
$
|
2.08
|
|
|
|
1,878
|
|
|
$
|
2.46
|
|
Issued
|
|
|
985
|
|
|
$
|
0.50
|
|
|
|
–
|
|
|
$
|
–
|
|
Expired/Canceled
|
|
|
–
|
|
|
$
|
–
|
|
|
|
(39
|
)
|
|
$
|
15.63
|
|
Outstanding at end of period
|
|
|
2,813
|
|
|
$
|
1.53
|
|
|
|
1,839
|
|
|
$
|
2.18
|
|
Exercisable at end of period
|
|
|
2,813
|
|
|
$
|
1.53
|
|
|
|
1,839
|
|
|
$
|
2.18
|
|
iSign Solutions Inc.
FORM 10-Q
(In thousands, except per share amounts)
|
5.
|
Stockholders’ Equity (Deficit)
(continued)
|
A summary of the status of the warrants outstanding
and exercisable to purchase shares of Common Stock as of March 31, 2019 is as follows:
Number of Shares
|
|
|
Weighted Average
Remaining Life
|
|
|
Weighted Average
Exercise Price
per share
|
|
|
|
|
|
|
|
|
|
|
1,551
|
|
|
|
2.2
|
|
|
$
|
2.18
|
|
|
277
|
|
|
|
0.5
|
|
|
$
|
1.63
|
|
|
985
|
|
|
|
2.9
|
|
|
$
|
0.50
|
|
|
2,813
|
|
|
|
2.3
|
|
|
$
|
1.53
|
|
iSign Solutions Inc.
FORM 10-Q
(In thousands, except per share amounts)
Forward Looking Statements
Certain statements
contained in this quarterly report on Form 10-Q, including, without limitation, statements containing the words “believes”,
“anticipates”, “hopes”, “intends”, “expects”, and other words of similar import,
constitute “forward looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995.
Such statements involve known and unknown risks, uncertainties and other factors which may cause actual events to differ materially
from expectations. Such factors include those set forth in the Company’s Annual Report on Form 10-K for the year ended December
31, 2018, including the following:
|
·
|
Technological,
engineering, manufacturing, quality control or other circumstances that could delay the
sale or shipment of products;
|
|
·
|
Economic,
business, market and competitive conditions in the software industry and technological
innovations that could affect the Company’s business;
|
|
·
|
The
Company’s inability to protect its trade secrets or other proprietary rights, operate
without infringing upon the proprietary rights of others and prevent others from infringing
on the proprietary rights of the Company; and
|
|
·
|
General
economic and business conditions and the availability of sufficient financing.
|
Except as otherwise
required by applicable laws, the Company undertakes no obligation to publicly update or revise any forward-looking statements,
as a result of new information, future events or otherwise.
Item 2.
Management’s
Discussion and Analysis of Financial Condition and Results of Operations.
The following discussion
and analysis should be read in conjunction with the Company’s unaudited condensed consolidated financial statements and
notes thereto included in Part 1, Item 1 of this quarterly report on Form 10-Q and “Management’s Discussion and Analysis
of Financial Condition and Results of Operations” set forth in the Company’s Annual report on Form 10-K for the fiscal
year ended December 31, 2018.
Overview
The Company is a
leading supplier of digital transaction management (DTM) software enabling the paperless, secure and cost-effective management
of document-based transactions. iSign’s solutions encompass a wide array of functionality and services, including electronic
signatures, biometric authentication and simple-to-complex workflow management. These solutions are available across virtually
all enterprise, desktop and mobile environments as a seamlessly integrated platform for both ad-hoc and fully automated transactions.
iSign’s software platform can be deployed both on-premise and as a cloud-based service, with the ability to easily
transition between deployment models.
The Company was incorporated
in Delaware in October 1986. Except for the year ended December 31, 2004, in each year since its inception the Company has incurred
losses. For the two-year period ended December 31, 2018, net losses aggregated approximately $2,974, and, at March 31, 2019, the
Company’s accumulated deficit was approximately $133,880.
For the three months
ended March 31, 2019, total revenue was $199, a decrease of $15, or 7%, compared to total revenue of $214 in the prior year period.
The decrease in revenue is primarily attributable to a decrease in the Company’s maintenance revenue for the quarter.
The net loss for
the three months ended March 31, 2019 was $291, an increase of $7, or 2%, compared to a net loss of $284 in the prior year period.
The increase in net loss is due to the increase in interest expense of $23 or 61%, offset by the decrease in the amortization
of debt discount.
iSign Solutions Inc.
FORM 10-Q
(In thousands, except per share amounts)
Critical Accounting Policies
and Estimates
Refer to Item 7,
“Management Discussion and Analysis of Financial Condition and Results of Operations” in the Company’s 2018
Form 10-K.
Effect of Recent Accounting Pronouncement
Accounting Standards
Updates issued as of March 31, 2019 are not expected to have a material impact on the Company’s financial position, results
of operations and cash flows.
Results of Operations
Revenue
For the three months
ended March 31, 2019, product revenue was $41, an increase of $1, or 3%, compared to product revenue of $40 in the prior year
period. The increase in product revenue is primarily due to transaction volume compared to the prior year quarter. For the three
months ended March 31, 2019, maintenance revenue was $158, a decrease of $16, or 9%, compared to maintenance revenue of $174 in
the prior year period. The decrease in maintenance revenue was due to the non-renewal of certain maintenance contracts during
2018.
Cost of Sales
For the three months
ended March 31, 2019, cost of sales was $18, an increase of $8, or 80%, compared to cost of sales of $10 in the prior year period.
The increase in cost of sales is primarily attributable to the increase in direct engineering costs associated with maintenance
activities compared to the prior year period.
Operating expenses
Research and Development Expenses
For the three months
ended March 31, 2019, research and development expense was $171, a decrease of $58, or 25%, compared to research and development
expense of $229 in the prior year period. Research and development expenses consist primarily of salaries and related costs, outside
engineering, maintenance items, and allocated facilities expenses. The decrease in research and development expense was due to
a reduction in salaries and related expenses due to a reduction in headcount of one engineer, and reductions in the utilization
of outside engineering services and facilities expense compared to the prior year. Gross engineering expenses, before allocations
to cost of sales, decreased by $58, or 23%, compared to the prior year period, due primarily to the same factors discussed above.
Sales and Marketing Expenses
For the three months
ended March 31, 2019, sales and marketing expense was $26, an increase of $7, or 37%, compared to $19 in the prior year period.
The increase was primarily attributable to an increase in commissions and professional services in connection with the Company’s
efforts to restructure its operations in favor of partner-generated recurring revenue.
General and Administrative Expenses
For the three months
ended March 31, 2019, general and administrative expense was $204, an increase of $28, or 16%, compared to general and administrative
expense of $176 in the prior year period. The increase was due primarily to increases in stock option compensation expense of
$27, offset by reductions of $4 in other administrative overhead expenses, compared to the prior year period.
iSign Solutions Inc.
FORM 10-Q
(In thousands, except per share amounts)
Other income and expense
Interest expense
for the three months ended March 31, 2019 was $61, an increase of $23, or 61% compared to interest expense of $38 in the prior
year period. The increase is due to an increase in short-term debt and other unpaid interest bearing liabilities. Interest expense
on short-term debt associated with related parties was $14 and non-related party interest expense was $47.
Amortization of debt
discount was $10 for the three months ended March 31, 2019, a decrease of $14, or 58% compared to $24 in the prior year period.
The extension of the due dates for the secured and unsecured convertible promissory notes to December 31, 2019 resulted in this
decline in amortization expense.
Liquidity and Capital Resources
At March 31, 2019,
cash and cash equivalents totaled $280, compared to cash and cash equivalents of $335 at December 31, 2018. The decrease in cash
was due to cash used in operating activities of $53 and cash used in investing activities of $2. At March 31, 2019, total current
assets were $382 compared to total current assets of $465 at December 31, 2018. At March 31, 2019, the Company’s principal
sources of funds included its cash and cash equivalents aggregating $280.
At March 31, 2019,
accounts receivable net, was $43, a decrease of $41, or 49%, compared to accounts receivable, net of $84 at December 31, 2018.
The decrease is due primarily to faster collection times for accounts receivable.
At March 31, 2019,
prepaid expenses and other current assets were $59, an increase of $13, or 28%, compared to prepaid expenses and other current
assets of $46 at December 31, 2018. The increase is due primarily to prepayments of certain engineering services during the quarter.
At March 31, 2019,
total current liabilities were $4,506, an increase of $130, or 3%, compared to total current liabilities of $4,376 at December
31, 2018.
At March 31, 2019,
accounts payable were $1,266, a decrease of $14, or 1%, from the December 31, 2018 balance of $1,280. The decrease is due primarily
to payments made during the quarter.
At March 31, 2019,
accrued compensation was $78, a decrease of $3, or 4%, compared to accrued compensation of $81 at December 31, 2018. The decrease
is due primarily to the payment of commissions and deferred compensation during the quarter ended March 31, 2019.
Other accrued liabilities
were $598, an increase of $74, or 14%, compared to other accrued liabilities of $524 at December 31, 2018, primarily due to the
accrual of interest on the Company’s debt and certain franchise taxes.
Deferred revenue,
including the long-term portion, was $362 at March 31, 2019, an increase of $45, or 14%, compared to deferred revenue of $317
at December 31, 2018. The increase is primarily due to the renewal of maintenance contracts offset by the recognition of maintenance
revenues during the quarter ended March 31, 2019.
For the three months
ended March 31, 2019, the Company incurred $61 of interest expense and $10 in amortization of debt discount. For the three months
ended March 31, 2018, the Company incurred $38 of interest expense and $24 in amortization of debt discount.
The Company had no
material commitments as of March 31, 2019.
The Company has experienced
recurring losses from operations that raise a substantial doubt about its ability to continue as a going concern. There can be
no assurance that the Company will have adequate capital resources to fund planned operations or that any additional funds will
be available to it when needed, or if available, will be available on favorable terms or in amounts required by it. If the Company
is unable to obtain adequate capital resources to fund operations, it may be required to delay, scale back or eliminate some or
all of its operations, which may have a material adverse effect on the Company’s business, results of operations and ability
to operate as a going concern.
iSign Solutions Inc.
FORM 10-Q
(In thousands, except per share amounts)
Item 3.
Quantitative
and Qualitative Disclosures About Market Risk.
Interest Rate Risk
The Company did not
enter into any short-term security investments during the three months ended March 31, 2019.
Foreign Currency Risk
From time to time,
the Company makes certain capital equipment or other purchases denominated in foreign currencies. As a result, the Company’s
cash flows and earnings are exposed to fluctuations in interest rates and foreign currency exchange rates. The Company attempts
to limit these exposures through operational strategies and generally has not hedged currency exposures. During the three months
ended March 31, 2019 and 2018, foreign currency translation gains and losses were insignificant.
Item 4.
Controls and Procedures
.
Disclosure Controls and Procedures
The Company carried
out an evaluation as of the end of the period covered by this report, under the supervision and with the participation of our
management, including our Chief Executive Officer and our Chief Financial Officer, of the effectiveness of our disclosure controls
and procedures pursuant to paragraph (b) of Rule 13a-15 and 15d-15 under the Exchange Act of 1934 (the “Exchange Act”).
Based on that evaluation and because of the material weaknesses in our internal control over financial reporting described below,
the Chief Executive Officer and the Chief Financial Officer have concluded that our disclosure controls and procedures were not
effective to ensure that information required to be disclosed by the Company in the reports it files or submits under the Exchange
Act (1) is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms,
and (2) is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer,
as appropriate to allow timely decisions regarding required disclosures.
Management identified
the following control deficiencies that constitute material weaknesses that are not fully remediated as of the filing date of
this report:
As a small company
with limited resources that are mainly focused on the development and sales of software products and services, iSign does not
employ a sufficient number of staff in its finance department to possess an optimal segregation of duties or to provide optimal
levels of oversight. This has resulted in certain audit adjustments and management believes that there may be a possibility for
a material misstatement to occur in future periods while it employs the current number of personnel in its finance department.
The Company does
not expect that its disclosure controls and procedures will prevent all error and all fraud. A control procedure, no matter how
well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control procedures
are met. Because of the inherent limitations in all control procedures, no evaluation of controls can provide absolute assurance
that all control issues and instances of fraud, if any, within the Company have been detected. These inherent limitations include
the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of simple error or mistake.
Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management
override of the control. The Company considered these limitations during the development of its disclosure controls and procedures,
and will continually reevaluate them to ensure they provide reasonable assurance that such controls and procedures are effective.
Changes in Internal Control over Financial
Reporting
There has been no
change in our internal control over financial reporting during the quarter ended March 31, 2019 that has materially affected,
or is reasonably likely to materially affect, our internal control over financial reporting.
iSign Solutions Inc.
FORM 10-Q
(In thousands, except per share amounts)